With reference to the news item appearing in a leading financial daily titled `Hester Pharma plans acquisition in Europe`, the company clarified that it has not confirmed such kind of activity.
The company registered a 65.75% growth in net profit to Rs 20.52 million for the quarter ended December 2007 from a profit of Rs 12.38 million for the quarter ended in December 2006.
Shares of the company declined Rs 0.5, or 0.38%, to trade at Rs 129.5. The total volume of shares traded was 4,442 at the BSE. (3.01 p.m., Thursday)